NFKB1 and COVID-19: The serum levels of IL-2, IL-6, TNF-α, IL-1β, IL-10, IFN-γ, IL-8, and IP-10 are significantly increased in patients with severe COVID-19 (70), possibly via selective activation of NF-κB.